Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2611-2618

  Schlieper, Georg ^a   Hristov, Mihail ^a   Brandenburg, Vincent ^a   Krüger, Thilo ^a   Westenfeld, Ralf ^a   Mahnken, Andreas H ^a   Yagmur, Eray ^a   Boecker, Georg ^b   Heussen, Nicole ^c   Gladziwa, Ulrich ^b,d   Ketteler, Markus ^a,e   Weber, Christian ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Dialysis Center   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e KLINIKUM COBURG   (Germany)

Author keywords

Calcification; Cardiovascular disease; Chronic haemodialysis; Endothelial progenitor cells; Fetuin A

Indexed keywords

FETUIN A; LECTIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL COUNT; CELL ISOLATION; CELL MIGRATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PULSE WAVE; RETICULOCYTE; SCORING SYSTEM; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEM CELL; UREMIA;

ADULT STEM CELLS; AGED; BLOOD CELL COUNT; BLOOD PROTEINS; CALCINOSIS; CASE-CONTROL STUDIES; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETICULOCYTES; RISK FACTORS;

EID: 48749085085     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn103     Document Type: Article

References (47)

1. US Renal Data System. USRDS 1998 Annual Data Report. National Institute of Diabetes and Kidney Diseases, Bethesda, MD, 1999, 63-90.
2. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
3. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003; 14: 159-168
4. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
5. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
6. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
7. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
8. Passauer J, Bussemaker E, Range U et al. Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis. J Am Soc Nephrol 2000; 11: 1726-1734
9. Farkas K, Nemcsik J, Kolossvary E et al. Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrol Dial Transplant 2005; 20: 1821-1827
10. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967
11. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438
12. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436
13. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-463
14. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498-508
15. Rabelink TJ, de Boer HC, de Koning EJ et al. Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 2004; 24: 834-838
16. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600
17. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987
18. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007
19. Leor J, Marber M. Endothelial progenitors: a new Tower of Babel? J Am Coll Cardiol 2006; 48: 1588-1590
20. Guven H, Shepherd RM, Bach RG et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006; 48: 1579-1587
21. Herbrig K, Pistrosch F, Oelschlaegel U et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849
22. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252
23. Steiner S, Schaller G, Puttinger H et al. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis 2005; 46: 520-528
24. Hristov M, Fach C, Becker C et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-termstatin treatment. Atherosclerosis 2007; 192: 413-420
25. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786
26. Ix JH, Shlipak MG, Brandenburg VM et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113: 1760-1767
27. Haydar AA, Covic A, Colhoun H et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65: 1790-1794
28. De Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646
29. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005; 289: F679-F684
30. Hughes AD, Coady E, Raynor S et al. Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis. Eur J Clin Invest 2007; 37: 35-41
31. +cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007; 191: 115-120
32. Gross ML, Meyer HP, Ziebart H et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and X-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2007; 2: 121-134
33. Leone AM, Rutella S, Bonanno G et al. Mobilization of bone marrow-derived stem cells aftermyocardial infarction and left ventricular function. Eur Heart J 2005; 26: 1196-1204
34. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779
35. Caglar K, Yilmaz MI, Saglam M et al. Endothelial dysfunction and fetuin A levels before and after kidney transplantation. Transplantation 2007; 83: 392-397
36. Hermans MM, Kooman JP, Brandenburg V et al. Spatial inhomogeneity of common carotid artery intima-media is increased in dialysis patients. Nephrol Dial Transplant 2007; 22: 1205-1212
37. Lebreton JP, Joisel F, Raoult JP et al. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64: 1118-1129
38. Mayr FB, Spiel AO, Leitner JM et al. Effects of low dose endotoxemia on endothelial progenitor cells in humans. Atherosclerosis 2007; 195: e202-e206
39. Rafat N, Hanusch C, Brinkkoetter PT et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 2007; 35: 1677-1684
40. Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926
41. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
42. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
43. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890
44. Rehman J, Li J, Parvathaneni L et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004; 43: 2314-2318
45. Redondo S, Hristov M, Gumbel D et al. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of PPAR-γ and TGF-β1. Thromb Haemost 2007; 97: 979-987
46. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
47. Herbrig K, Gebler K, Oelschlaegel U et al. Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end-stage renal disease. Am J Transplant 2006; 6: 2922-2928